Improving the lives of children with glaucoma
Thanks to generous supporters of eye health at Flinders, researchers are hoping to improve the lives of children with glaucoma by identifying genes which lead to more severe outcomes, while also focusing on methods to improve quality of life for patients, and their families.
Lachlan Knight has received a Flinders Foundation top-up PhD scholarship to study 300 cases of childhood glaucoma in Australia and New Zealand.
“Childhood glaucoma is largely considered to be a genetic condition, yet we’ve found a ‘genetic answer’ for only around 40 per cent of patients,” Lachlan explains.
“This project is really looking at how many children are affected by the condition, what genes cause it, and if some genes cause more severe disease or have a greater impact on vision.
“If we can pinpoint this, then we hope to be able to identify those at risk of worse outcomes so they can get closer follow up and more intensive treatment to stop the progression of glaucoma.”
Lachlan’s work is also the first project in Australia, and one of just a few worldwide, to investigate the quality of life of kids with glaucoma and their families. Glaucoma is a rare condition caused by pressure on the optic nerve.
“Childhood glaucoma is a chronic condition needing life-long follow up,” Lachlan says.
“Some patients have vision loss and can have learning difficulties and social problems which stem from that, there can also be feelings of isolation and being misunderstood because there is a lack of awareness of the disease.
“For parents, they talk about stress, strong emotions and strain on the family, because many worry constantly for their child and what the future looks like for them.
“Some of these stories are quite heartbreaking, so this work is really looking at how families cope, what help they need, and how we can get them the necessary support.”
Laughter really is the best medicine
An Australian-first pilot program at Flinders Medical Centre is brightening up hospital stays for elderly patients - many of whom have dementia.
Scholarship shines spotlight on sleep conditions
Flinders researchers hope to improve sleep quality and breathlessness among patients with highly prevalent sleep conditions, with the help of a Clinician PhD Scholarship co-funded by Flinders Foundation and Flinders Health and Medical Research Institute (FHMRI).
The Simonds Charity Home SOLD
It was a fun morning of games and giveaways in Lightsview. Local families and prospective buyers walked through the incredible two-storey home before an action-packed auction.
The Simonds Charity Home
Flinders Foundation is teaming up with The Great Australian Builder, Simonds Homes, to support thousands of South Australian children and families who need care in hospital.
2022 Flinders Foundation Health Seed Grant Round now open
The 2022 Flinders Foundation Health Seed Grant Round is now open to all eligible researchers across the Flinders medical precinct, including Flinders University researchers involved in health and medical research.
Combatting blinding cancer
Thanks to your support, treatments for a rare eye cancer that can spread to the brain will be analysed at Flinders University using data from a new international registry.
Dedicated Outreach Nurse joins Cancer Wellness Centre
A partnership between Flinders Foundation and Cancer Council SA is providing a dedicated nurse for people affected by cancer in the Flinders Cancer Wellness Centre.
Jane’s Wish – the Jane Watson Ramsey PhD Scholarship in Multiple Myeloma Research
Ali Habib, recipient of the inaugural Jane Watson Ramsey PhD Scholarship in Multiple Myeloma Research, says Jane and Bill’s generosity is providing him with the opportunity to make a difference for people living with the incurable disease.
The Ryan Hodges Scholarship in Precision Dosing
The Ryan Hodges Scholarship in Precision Dosing has been established in memory of Ryan, who passed away in October 2021.
Giving hope to people with brain cancer
Often, by the time a person is diagnosed with brain cancer, it’s too late to cure them.